Meet Dr. James Reynolds, a Professor and Researcher at Queens University. Here, in a discussion with Dr. Emily Bell, he discusses the potential for using biomarkers to screen for Fetal Alcohol Syndrome Disorder, the associated risks and benefits of this, and ethical implications.

This 'Conversations in Neuroethics for Neurodevelopmental disorders' series was created by NeuroDevNet, the Knowledge Translation Core and National Core for Neuroethics. Please visit neuroethicscanada.ca and neurodevnet.ca to find short videos, reference lists and more.

James Reynolds- FASD And Prenatal Screening

The National Core for Neuroethics is an interdisciplinary research group dedicated to tackling the ethical, legal, policy and social implications of frontier technological developments in the neurosciences. Our objective is to align innovations in the brain sciences with societal, cultural and individual human values through high impact research, education and outreach.

The Core’s major research  projects are focused on high impact, high visibility areas including cognitive enhancement, ethics in neurodegeneration and regenerative medicine, international and cross-cultural challenges in brain research, neuroimaging in the private sector, and the ethics of personalized medicine, among others. For an overview of our recent work, please see our most recent Annual Report here.

We are located  at the University of British Columbia Hospital in Vancouver, Canada.


James Reynolds- FASD And Prenatal Screening

Neuroethics Core